The post discusses a bullish long-term investment position in SDGR using $40,000 worth of LEAP options (long-dated call options). Key risks include time decay on options, volatility exposure, and the leveraged nature of derivative instruments which can result in total loss of capital if the stock doesn't move as anticipated.

User bullish on SDGR due to AI-biotech potential and has invested $40K in LEAPS calls, betting on significant upside. Key risks include biotech volatility, execution risk on AI initiatives, and LEAPS leverage exposure to time decay and market downturns.